Biolase Technology, Inc. (BLTI) Misses Q1 EPS by 1c

Biolase Technology, Inc. (NASDAQ: BLTI) reported Q1 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10.51 million.

For earnings history and earnings-related data on Biolase Technology, Inc. (BLTI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Mount Logan's Ability Insurance launches MYGA annuity products
• Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS